Ebola Vaccine
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure (NCT05959421) | Universitätsklinikum Hamburg-Eppendorf | 2026-06-01 |
| Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers (NCT02464670) | Inovio Pharmaceuticals | 2015-05-01 |
Track Ebola Vaccine automatically
Every clearance here is in the API, with alerts when new ones post.